nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.11	0.236	CbGbCtD
Ropivacaine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0693	0.149	CbGbCtD
Ropivacaine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0554	0.119	CbGbCtD
Ropivacaine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0471	0.101	CbGbCtD
Ropivacaine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0363	0.0781	CbGbCtD
Ropivacaine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0338	0.0726	CbGbCtD
Ropivacaine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0316	0.0678	CbGbCtD
Ropivacaine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0271	0.0583	CbGbCtD
Ropivacaine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0155	0.0333	CbGbCtD
Ropivacaine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0152	0.0328	CbGbCtD
Ropivacaine—SCN3A—spinal nerve—peripheral nervous system neoplasm	0.0152	0.391	CbGeAlD
Ropivacaine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0142	0.0305	CbGbCtD
Ropivacaine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00969	0.0208	CbGbCtD
Ropivacaine—SCN8A—nerve—peripheral nervous system neoplasm	0.0048	0.124	CbGeAlD
Ropivacaine—SCN5A—Cardiac Progenitor Differentiation—LIN28B—peripheral nervous system neoplasm	0.00385	0.0664	CbGpPWpGaD
Ropivacaine—SCN10A—nerve—peripheral nervous system neoplasm	0.00321	0.0827	CbGeAlD
Ropivacaine—SCN10A—ganglion—peripheral nervous system neoplasm	0.00317	0.0816	CbGeAlD
Ropivacaine—SCN8A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.0025	0.0431	CbGpPWpGaD
Ropivacaine—SCN8A—brainstem—peripheral nervous system neoplasm	0.00206	0.053	CbGeAlD
Ropivacaine—SCN9A—trigeminal ganglion—peripheral nervous system neoplasm	0.00205	0.0527	CbGeAlD
Ropivacaine—SCN9A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00202	0.0348	CbGpPWpGaD
Ropivacaine—SCN3A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00193	0.0333	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00185	0.032	CbGpPWpGaD
Ropivacaine—SCN4A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00185	0.032	CbGpPWpGaD
Ropivacaine—SCN1A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00179	0.0309	CbGpPWpGaD
Ropivacaine—SCN10A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00179	0.0309	CbGpPWpGaD
Ropivacaine—SCN10A—trigeminal ganglion—peripheral nervous system neoplasm	0.00156	0.0401	CbGeAlD
Ropivacaine—SCN1A—brainstem—peripheral nervous system neoplasm	0.00156	0.0401	CbGeAlD
Ropivacaine—SCN2A—brainstem—peripheral nervous system neoplasm	0.00143	0.0368	CbGeAlD
Ropivacaine—SCN5A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00126	0.0217	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00123	0.0212	CbGpPWpGaD
Ropivacaine—SCN8A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00122	0.021	CbGpPWpGaD
Ropivacaine—SCN8A—cerebellum—peripheral nervous system neoplasm	0.00102	0.0262	CbGeAlD
Ropivacaine—SCN5A—Cardiac Progenitor Differentiation—NCAM1—peripheral nervous system neoplasm	0.000988	0.017	CbGpPWpGaD
Ropivacaine—SCN9A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000986	0.017	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000943	0.0163	CbGpPWpGaD
Ropivacaine—SCN3A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000943	0.0163	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000906	0.0156	CbGpPWpGaD
Ropivacaine—SCN4A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000906	0.0156	CbGpPWpGaD
Ropivacaine—SCN1A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000873	0.0151	CbGpPWpGaD
Ropivacaine—SCN10A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000873	0.0151	CbGpPWpGaD
Ropivacaine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000871	0.015	CbGpPWpGaD
Ropivacaine—SCN1A—cerebellum—peripheral nervous system neoplasm	0.000768	0.0198	CbGeAlD
Ropivacaine—SCN9A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000763	0.0132	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00073	0.0126	CbGpPWpGaD
Ropivacaine—SCN2A—cerebellum—peripheral nervous system neoplasm	0.000705	0.0181	CbGeAlD
Ropivacaine—SCN4A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000701	0.0121	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000701	0.0121	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000676	0.0117	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000676	0.0117	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000673	0.0116	CbGpPWpGaD
Ropivacaine—SCN3A—cerebellum—peripheral nervous system neoplasm	0.00062	0.0159	CbGeAlD
Ropivacaine—SCN5A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000614	0.0106	CbGpPWpGaD
Ropivacaine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00057	0.00983	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000544	0.00939	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000521	0.00898	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.0005	0.00863	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.0005	0.00863	CbGpPWpGaD
Ropivacaine—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000483	0.00834	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000482	0.00832	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000482	0.00832	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000475	0.0082	CbGpPWpGaD
Ropivacaine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.00047	0.0121	CbGeAlD
Ropivacaine—SCN8A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000461	0.00795	CbGpPWpGaD
Ropivacaine—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000414	0.00713	CbGpPWpGaD
Ropivacaine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000394	0.0068	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000372	0.00643	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000356	0.00615	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000354	0.00611	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.000343	0.00592	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000342	0.00591	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000342	0.00591	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000339	0.00585	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00033	0.00569	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00033	0.00569	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000329	0.00567	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000324	0.0056	CbGpPWpGaD
Ropivacaine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000312	0.00538	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000266	0.00459	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000264	0.00456	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000254	0.00439	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000244	0.00421	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000244	0.00421	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000236	0.00406	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000236	0.00406	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000232	0.004	CbGpPWpGaD
Ropivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000232	0.004	CbGpPWpGaD
Ropivacaine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000232	0.00596	CbGeAlD
Ropivacaine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000231	0.000527	CcSEcCtD
Ropivacaine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000231	0.000527	CcSEcCtD
Ropivacaine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000231	0.000527	CcSEcCtD
Ropivacaine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00023	0.000526	CcSEcCtD
Ropivacaine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00023	0.000526	CcSEcCtD
Ropivacaine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00023	0.000525	CcSEcCtD
Ropivacaine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00023	0.000524	CcSEcCtD
Ropivacaine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00023	0.000524	CcSEcCtD
Ropivacaine—Pain—Vincristine—peripheral nervous system neoplasm	0.00023	0.000524	CcSEcCtD
Ropivacaine—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000524	CcSEcCtD
Ropivacaine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00023	0.000524	CcSEcCtD
Ropivacaine—Rash—Melphalan—peripheral nervous system neoplasm	0.000229	0.000523	CcSEcCtD
Ropivacaine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000229	0.000522	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000228	0.00052	CcSEcCtD
Ropivacaine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000227	0.000518	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000517	CcSEcCtD
Ropivacaine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000516	CcSEcCtD
Ropivacaine—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000516	CcSEcCtD
Ropivacaine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000224	0.000512	CcSEcCtD
Ropivacaine—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000512	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000223	0.00051	CcSEcCtD
Ropivacaine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000222	0.000507	CcSEcCtD
Ropivacaine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000221	0.000506	CcSEcCtD
Ropivacaine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000221	0.000505	CcSEcCtD
Ropivacaine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00022	0.000503	CcSEcCtD
Ropivacaine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00022	0.000503	CcSEcCtD
Ropivacaine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00022	0.000503	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—MET—peripheral nervous system neoplasm	0.00022	0.0038	CbGpPWpGaD
Ropivacaine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00022	0.000501	CcSEcCtD
Ropivacaine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000219	0.000501	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000219	0.0005	CcSEcCtD
Ropivacaine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000218	0.000499	CcSEcCtD
Ropivacaine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000218	0.000499	CcSEcCtD
Ropivacaine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000498	CcSEcCtD
Ropivacaine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000218	0.000497	CcSEcCtD
Ropivacaine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000497	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000216	0.000494	CcSEcCtD
Ropivacaine—Infection—Etoposide—peripheral nervous system neoplasm	0.000216	0.000493	CcSEcCtD
Ropivacaine—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000493	CcSEcCtD
Ropivacaine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000216	0.000492	CcSEcCtD
Ropivacaine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000216	0.000492	CcSEcCtD
Ropivacaine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000213	0.000487	CcSEcCtD
Ropivacaine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000213	0.000486	CcSEcCtD
Ropivacaine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000212	0.000485	CcSEcCtD
Ropivacaine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000212	0.000485	CcSEcCtD
Ropivacaine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000212	0.000485	CcSEcCtD
Ropivacaine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000212	0.000483	CcSEcCtD
Ropivacaine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000211	0.000482	CcSEcCtD
Ropivacaine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00021	0.00048	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000479	CcSEcCtD
Ropivacaine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000477	CcSEcCtD
Ropivacaine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000474	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000472	CcSEcCtD
Ropivacaine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000206	0.00047	CcSEcCtD
Ropivacaine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000205	0.000469	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000204	0.00351	CbGpPWpGaD
Ropivacaine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000203	0.000464	CcSEcCtD
Ropivacaine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000203	0.000464	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000462	CcSEcCtD
Ropivacaine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000458	CcSEcCtD
Ropivacaine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.0002	0.000457	CcSEcCtD
Ropivacaine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000456	CcSEcCtD
Ropivacaine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000198	0.000452	CcSEcCtD
Ropivacaine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.00045	CcSEcCtD
Ropivacaine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000196	0.000447	CcSEcCtD
Ropivacaine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000195	0.000446	CcSEcCtD
Ropivacaine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000194	0.000443	CcSEcCtD
Ropivacaine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000442	CcSEcCtD
Ropivacaine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000193	0.000442	CcSEcCtD
Ropivacaine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000193	0.00044	CcSEcCtD
Ropivacaine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000437	CcSEcCtD
Ropivacaine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000191	0.000436	CcSEcCtD
Ropivacaine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000191	0.000435	CcSEcCtD
Ropivacaine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00019	0.000433	CcSEcCtD
Ropivacaine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000188	0.00324	CbGpPWpGaD
Ropivacaine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000188	0.000429	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000428	CcSEcCtD
Ropivacaine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000426	CcSEcCtD
Ropivacaine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000186	0.000425	CcSEcCtD
Ropivacaine—Pain—Etoposide—peripheral nervous system neoplasm	0.000186	0.000425	CcSEcCtD
Ropivacaine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000424	CcSEcCtD
Ropivacaine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000424	CcSEcCtD
Ropivacaine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000184	0.000421	CcSEcCtD
Ropivacaine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000184	0.00042	CcSEcCtD
Ropivacaine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000416	CcSEcCtD
Ropivacaine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000179	0.000409	CcSEcCtD
Ropivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000179	0.00309	CbGpPWpGaD
Ropivacaine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000409	CcSEcCtD
Ropivacaine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000179	0.000408	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—MET—peripheral nervous system neoplasm	0.000178	0.00307	CbGpPWpGaD
Ropivacaine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000178	0.000406	CcSEcCtD
Ropivacaine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000178	0.000405	CcSEcCtD
Ropivacaine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.000405	CcSEcCtD
Ropivacaine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000404	CcSEcCtD
Ropivacaine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.000401	CcSEcCtD
Ropivacaine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.000401	CcSEcCtD
Ropivacaine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000175	0.000399	CcSEcCtD
Ropivacaine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000399	CcSEcCtD
Ropivacaine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000175	0.000399	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000396	CcSEcCtD
Ropivacaine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000173	0.000395	CcSEcCtD
Ropivacaine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000394	CcSEcCtD
Ropivacaine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000393	CcSEcCtD
Ropivacaine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000172	0.000393	CcSEcCtD
Ropivacaine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000172	0.000393	CcSEcCtD
Ropivacaine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000393	CcSEcCtD
Ropivacaine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000171	0.00039	CcSEcCtD
Ropivacaine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000171	0.00039	CcSEcCtD
Ropivacaine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00017	0.000389	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—MET—peripheral nervous system neoplasm	0.00017	0.00294	CbGpPWpGaD
Ropivacaine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000387	CcSEcCtD
Ropivacaine—Rash—Vincristine—peripheral nervous system neoplasm	0.000169	0.000387	CcSEcCtD
Ropivacaine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000169	0.000386	CcSEcCtD
Ropivacaine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000386	CcSEcCtD
Ropivacaine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000385	CcSEcCtD
Ropivacaine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000384	CcSEcCtD
Ropivacaine—Headache—Vincristine—peripheral nervous system neoplasm	0.000168	0.000384	CcSEcCtD
Ropivacaine—SCN5A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000166	0.00286	CbGpPWpGaD
Ropivacaine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000166	0.000378	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000165	0.00284	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MET—peripheral nervous system neoplasm	0.000164	0.00282	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MET—peripheral nervous system neoplasm	0.000164	0.00282	CbGpPWpGaD
Ropivacaine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000162	0.000371	CcSEcCtD
Ropivacaine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000369	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000161	0.00278	CbGpPWpGaD
Ropivacaine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00016	0.000366	CcSEcCtD
Ropivacaine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000365	CcSEcCtD
Ropivacaine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00016	0.000364	CcSEcCtD
Ropivacaine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000364	CcSEcCtD
Ropivacaine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000364	CcSEcCtD
Ropivacaine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000361	CcSEcCtD
Ropivacaine—SCN1A—Axon guidance—MET—peripheral nervous system neoplasm	0.000158	0.00272	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MET—peripheral nervous system neoplasm	0.000158	0.00272	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000157	0.00272	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000157	0.00271	CbGpPWpGaD
Ropivacaine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000358	CcSEcCtD
Ropivacaine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000357	CcSEcCtD
Ropivacaine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000156	0.000356	CcSEcCtD
Ropivacaine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000355	CcSEcCtD
Ropivacaine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000352	CcSEcCtD
Ropivacaine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000154	0.000351	CcSEcCtD
Ropivacaine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00035	CcSEcCtD
Ropivacaine—SCN4A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000151	0.00261	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000151	0.00261	CbGpPWpGaD
Ropivacaine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000151	0.000345	CcSEcCtD
Ropivacaine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000343	CcSEcCtD
Ropivacaine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00015	0.000342	CcSEcCtD
Ropivacaine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00015	0.000342	CcSEcCtD
Ropivacaine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000341	CcSEcCtD
Ropivacaine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000149	0.00034	CcSEcCtD
Ropivacaine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000338	CcSEcCtD
Ropivacaine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000337	CcSEcCtD
Ropivacaine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000335	CcSEcCtD
Ropivacaine—SCN10A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000146	0.00252	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000146	0.00252	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000145	0.00251	CbGpPWpGaD
Ropivacaine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000331	CcSEcCtD
Ropivacaine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000145	0.00033	CcSEcCtD
Ropivacaine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000144	0.000328	CcSEcCtD
Ropivacaine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000328	CcSEcCtD
Ropivacaine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000325	CcSEcCtD
Ropivacaine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000324	CcSEcCtD
Ropivacaine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000141	0.000322	CcSEcCtD
Ropivacaine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000321	CcSEcCtD
Ropivacaine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000318	CcSEcCtD
Ropivacaine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000317	CcSEcCtD
Ropivacaine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000138	0.000316	CcSEcCtD
Ropivacaine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000316	CcSEcCtD
Ropivacaine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000315	CcSEcCtD
Ropivacaine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000313	CcSEcCtD
Ropivacaine—Rash—Etoposide—peripheral nervous system neoplasm	0.000137	0.000313	CcSEcCtD
Ropivacaine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000137	0.000313	CcSEcCtD
Ropivacaine—Headache—Etoposide—peripheral nervous system neoplasm	0.000136	0.000311	CcSEcCtD
Ropivacaine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00031	CcSEcCtD
Ropivacaine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000308	CcSEcCtD
Ropivacaine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000307	CcSEcCtD
Ropivacaine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000306	CcSEcCtD
Ropivacaine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000306	CcSEcCtD
Ropivacaine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000305	CcSEcCtD
Ropivacaine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000303	CcSEcCtD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000132	0.00228	CbGpPWpGaD
Ropivacaine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000131	0.0003	CcSEcCtD
Ropivacaine—Cough—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000298	CcSEcCtD
Ropivacaine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000297	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00013	0.00224	CbGpPWpGaD
Ropivacaine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000296	CcSEcCtD
Ropivacaine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000129	0.000295	CcSEcCtD
Ropivacaine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000295	CcSEcCtD
Ropivacaine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000293	CcSEcCtD
Ropivacaine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000292	CcSEcCtD
Ropivacaine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00029	CcSEcCtD
Ropivacaine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00029	CcSEcCtD
Ropivacaine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00029	CcSEcCtD
Ropivacaine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.00029	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000127	0.00219	CbGpPWpGaD
Ropivacaine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000289	CcSEcCtD
Ropivacaine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000287	CcSEcCtD
Ropivacaine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000285	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000124	0.00215	CbGpPWpGaD
Ropivacaine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000284	CcSEcCtD
Ropivacaine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000283	CcSEcCtD
Ropivacaine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000281	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000122	0.00211	CbGpPWpGaD
Ropivacaine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000278	CcSEcCtD
Ropivacaine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000277	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000122	0.0021	CbGpPWpGaD
Ropivacaine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000277	CcSEcCtD
Ropivacaine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000275	CcSEcCtD
Ropivacaine—Shock—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000274	CcSEcCtD
Ropivacaine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000273	CcSEcCtD
Ropivacaine—SCN2A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00012	0.00206	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.00012	0.00206	CbGpPWpGaD
Ropivacaine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000273	CcSEcCtD
Ropivacaine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000273	CcSEcCtD
Ropivacaine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000272	CcSEcCtD
Ropivacaine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000118	0.00027	CcSEcCtD
Ropivacaine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000269	CcSEcCtD
Ropivacaine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000269	CcSEcCtD
Ropivacaine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000269	CcSEcCtD
Ropivacaine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000269	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000117	0.00203	CbGpPWpGaD
Ropivacaine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000268	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000117	0.00201	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000117	0.00201	CbGpPWpGaD
Ropivacaine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000266	CcSEcCtD
Ropivacaine—SCN1A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000115	0.00199	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000115	0.00199	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000115	0.00198	CbGpPWpGaD
Ropivacaine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000114	0.00026	CcSEcCtD
Ropivacaine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.00026	CcSEcCtD
Ropivacaine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000258	CcSEcCtD
Ropivacaine—SCN1A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000113	0.00194	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000113	0.00194	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000112	0.00194	CbGpPWpGaD
Ropivacaine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000256	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000254	CcSEcCtD
Ropivacaine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000253	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	0.000111	0.00191	CbGpPWpGaD
Ropivacaine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000252	CcSEcCtD
Ropivacaine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000252	CcSEcCtD
Ropivacaine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000251	CcSEcCtD
Ropivacaine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.00025	CcSEcCtD
Ropivacaine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000109	0.00025	CcSEcCtD
Ropivacaine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000249	CcSEcCtD
Ropivacaine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000248	CcSEcCtD
Ropivacaine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000248	CcSEcCtD
Ropivacaine—SCN2A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000108	0.00186	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000108	0.00186	CbGpPWpGaD
Ropivacaine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000245	CcSEcCtD
Ropivacaine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000241	CcSEcCtD
Ropivacaine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000238	CcSEcCtD
Ropivacaine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000238	CcSEcCtD
Ropivacaine—SCN10A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000104	0.0018	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000104	0.0018	CbGpPWpGaD
Ropivacaine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000235	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000103	0.00177	CbGpPWpGaD
Ropivacaine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000233	CcSEcCtD
Ropivacaine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000231	CcSEcCtD
Ropivacaine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00023	CcSEcCtD
Ropivacaine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000229	CcSEcCtD
Ropivacaine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000229	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	9.97e-05	0.000228	CcSEcCtD
Ropivacaine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.000227	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—NRAS—peripheral nervous system neoplasm	9.9e-05	0.00171	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.78e-05	0.00169	CbGpPWpGaD
Ropivacaine—Urticaria—Epirubicin—peripheral nervous system neoplasm	9.69e-05	0.000221	CcSEcCtD
Ropivacaine—Pain—Doxorubicin—peripheral nervous system neoplasm	9.65e-05	0.00022	CcSEcCtD
Ropivacaine—Constipation—Doxorubicin—peripheral nervous system neoplasm	9.65e-05	0.00022	CcSEcCtD
Ropivacaine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	9.64e-05	0.00022	CcSEcCtD
Ropivacaine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.64e-05	0.00022	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—NRAS—peripheral nervous system neoplasm	9.47e-05	0.00163	CbGpPWpGaD
Ropivacaine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.3e-05	0.000212	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	9.29e-05	0.0016	CbGpPWpGaD
Ropivacaine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.000211	CcSEcCtD
Ropivacaine—SCN4A—Axon guidance—NRAS—peripheral nervous system neoplasm	9.1e-05	0.00157	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—NRAS—peripheral nervous system neoplasm	9.1e-05	0.00157	CbGpPWpGaD
Ropivacaine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.000205	CcSEcCtD
Ropivacaine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000205	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—HRAS—peripheral nervous system neoplasm	8.95e-05	0.00154	CbGpPWpGaD
Ropivacaine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.92e-05	0.000204	CcSEcCtD
Ropivacaine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.92e-05	0.000204	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	8.88e-05	0.00153	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—NRAS—peripheral nervous system neoplasm	8.77e-05	0.00151	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—NRAS—peripheral nervous system neoplasm	8.77e-05	0.00151	CbGpPWpGaD
Ropivacaine—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.0002	CcSEcCtD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	8.73e-05	0.00151	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—NRAS—peripheral nervous system neoplasm	8.73e-05	0.00151	CbGpPWpGaD
Ropivacaine—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000197	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	8.53e-05	0.00147	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	8.53e-05	0.00147	CbGpPWpGaD
Ropivacaine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.34e-05	0.00019	CcSEcCtD
Ropivacaine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.31e-05	0.00019	CcSEcCtD
Ropivacaine—SCN1A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	8.23e-05	0.00142	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	8.23e-05	0.00142	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	8.11e-05	0.0014	CbGpPWpGaD
Ropivacaine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000185	CcSEcCtD
Ropivacaine—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.06e-05	0.000184	CcSEcCtD
Ropivacaine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000182	CcSEcCtD
Ropivacaine—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	7.91e-05	0.00137	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	7.76e-05	0.00134	CbGpPWpGaD
Ropivacaine—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.000177	CcSEcCtD
Ropivacaine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.72e-05	0.000176	CcSEcCtD
Ropivacaine—Rash—Epirubicin—peripheral nervous system neoplasm	7.69e-05	0.000176	CcSEcCtD
Ropivacaine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.68e-05	0.000175	CcSEcCtD
Ropivacaine—Headache—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000174	CcSEcCtD
Ropivacaine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.00017	CcSEcCtD
Ropivacaine—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	7.32e-05	0.00126	CbGpPWpGaD
Ropivacaine—Nausea—Epirubicin—peripheral nervous system neoplasm	7.24e-05	0.000165	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—HRAS—peripheral nervous system neoplasm	7.24e-05	0.00125	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	7.22e-05	0.00125	CbGpPWpGaD
Ropivacaine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000164	CcSEcCtD
Ropivacaine—Rash—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000162	CcSEcCtD
Ropivacaine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000162	CcSEcCtD
Ropivacaine—Headache—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.000161	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—NRAS—peripheral nervous system neoplasm	7.06e-05	0.00122	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—HRAS—peripheral nervous system neoplasm	6.93e-05	0.0012	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.8e-05	0.00117	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—NRAS—peripheral nervous system neoplasm	6.76e-05	0.00117	CbGpPWpGaD
Ropivacaine—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.7e-05	0.000153	CcSEcCtD
Ropivacaine—SCN2A—Axon guidance—HRAS—peripheral nervous system neoplasm	6.65e-05	0.00115	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—HRAS—peripheral nervous system neoplasm	6.65e-05	0.00115	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.61e-05	0.00114	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—NRAS—peripheral nervous system neoplasm	6.49e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—NRAS—peripheral nervous system neoplasm	6.49e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—HRAS—peripheral nervous system neoplasm	6.42e-05	0.00111	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—HRAS—peripheral nervous system neoplasm	6.42e-05	0.00111	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—HRAS—peripheral nervous system neoplasm	6.39e-05	0.0011	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—NRAS—peripheral nervous system neoplasm	6.26e-05	0.00108	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—NRAS—peripheral nervous system neoplasm	6.26e-05	0.00108	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	6.17e-05	0.00106	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	5.78e-05	0.000998	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.76e-05	0.000994	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	5.67e-05	0.000979	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.64e-05	0.000973	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—HRAS—peripheral nervous system neoplasm	5.17e-05	0.000892	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.94e-05	0.000853	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	4.78e-05	0.000824	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.75e-05	0.000819	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.75e-05	0.000819	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.59e-05	0.000792	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	4.58e-05	0.00079	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.58e-05	0.00079	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—HRAS—peripheral nervous system neoplasm	4.58e-05	0.00079	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.56e-05	0.000787	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	4.51e-05	0.000778	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.44e-05	0.000767	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	4.41e-05	0.000761	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	4.4e-05	0.000759	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.36e-05	0.000753	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.19e-05	0.000723	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.19e-05	0.000723	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.04e-05	0.000698	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—AKT1—peripheral nervous system neoplasm	4.04e-05	0.000698	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.89e-05	0.000671	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	3.32e-05	0.000573	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.23e-05	0.000558	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	3.22e-05	0.000555	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	3.18e-05	0.000549	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	3.06e-05	0.000529	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	3e-05	0.000518	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	2.89e-05	0.000499	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.84e-05	0.00049	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	2.81e-05	0.000485	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	2.7e-05	0.000465	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	2.6e-05	0.000448	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	2.45e-05	0.000422	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.33e-05	0.000402	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	2.3e-05	0.000397	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.17e-05	0.000374	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.08e-05	0.000359	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	2.01e-05	0.000347	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2e-05	0.000346	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	1.88e-05	0.000324	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.84e-05	0.000318	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.7e-05	0.000294	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.7e-05	0.000293	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.62e-05	0.00028	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.6e-05	0.000276	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.44e-05	0.000248	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.37e-05	0.000237	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.35e-05	0.000234	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.32e-05	0.000227	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.3e-05	0.000225	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.28e-05	0.000221	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.11e-05	0.000192	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.11e-05	0.000191	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.08e-05	0.000187	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.06e-05	0.000183	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.04e-05	0.00018	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	8.53e-06	0.000147	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	8.37e-06	0.000144	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	5.07e-06	8.74e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	3.52e-06	6.07e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.98e-06	5.15e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.3e-06	3.97e-05	CbGpPWpGaD
